Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants

Recruiting now

Conditions studied: Turner Syndrome

In brief

The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities. Thus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.

Key facts

Study ID

NCT06794190

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

120

Starts

2025-01-07

Expected to finish

2026-01-07

Last updated by the study team

2025-01-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
• Age 18 years or older
• Written informed consent obtained

You may not qualify if…

• TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.